Scholarly Index

Charles G. Drake

Johnson & Johnson (United States); 89,164 total citations; 699 total publications; best world rank #2

Johnson & Johnson (United States)

89,164Total citations
699Total publications
133H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Intracranial Aneurysms: Treatment and ComplicationsLifetime2US 199.93
Cancer Immunotherapy and BiomarkersLifetime11US 699.96
Immunotherapy and Immune ResponsesLifetime41US 2999.91
Vascular Malformations Diagnosis and TreatmentLifetime7US 799.86
CAR-T cell therapy researchLifetime73US 4599.68
Neurosurgical Procedures and ComplicationsLifetime25US 1599.57
Prostate Cancer Treatment and ResearchLifetime116US 7199.55
Immune Cell Function and InteractionLifetime335US 19399.55
Traumatic Brain Injury and Neurovascular DisturbancesLifetime170US 9899.32
Moyamoya disease diagnosis and treatmentLifetime31US 1598.99
Renal cell carcinoma treatmentLifetime289US 16698.61
T-cell and B-cell ImmunologyLifetime959US 47798.37
Cerebrovascular and Carotid Artery DiseasesLifetime846US 36797.95
Radiopharmaceutical Chemistry and ApplicationsLifetime578US 23597.22
Immune cells in cancerLifetime802US 32596.16
Meningioma and schwannoma managementLifetime504US 25397.40
Cerebrospinal fluid and hydrocephalusLifetime926US 41094.34
Inflammatory Biomarkers in Disease PrognosisLifetime675US 10390.74
Intracerebral and Subarachnoid Hemorrhage ResearchLifetime953US 35493.69
Cerebral Venous Sinus ThrombosisLifetime987US 45091.43
Vascular Anomalies and TreatmentsLifetime769US 27284.70
History of Medical PracticeLifetime414US 25780.76
Cancer Immunotherapy and Biomarkers2021-2025386US 15498.52
Immunotherapy and Immune Responses2021-2025221US 7496.80
Prostate Cancer Treatment and Research2021-2025681US 24594.29